Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and I…
This prospective, multinational, multicenter observational study follows patients with non-foveal, non-vision compromising atrophic age‑related macular degeneration for 24 months with 6‑month intervals. It aims to assess individual progression rates, identify focal and global retinal alterations, and evaluate monitoring using approved AI algorithms through routine imaging (Scanning Laser Fundus Photography, Color Fundus Photography, OCT, OCTA). No intervention is performed during the study, though treatment may be provided if approved in the EU.
Source: ClinicalTrials.gov